Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07369466

Association of Preoperative Hippocampal Glucose Metabolism With Postoperative Delirium in Older Diabetic Patients

Objective: To investigate the association between preoperative hippocampal glucose metabolism levels and the risk of postoperative delirium (POD) in elderly patients with type 2 diabetes (T2DM), and to provide a prospective neuroimaging biomarker for identifying high-risk populations.

Methods: This prospective cohort study plans to enroll 154 elderly T2DM patients scheduled for liver tumor resection at the First Medical Center of Chinese PLA General Hospital. Baseline cognitive function will be assessed using the Mini-Mental State Examination (MMSE) one day before surgery. Hippocampal glucose metabolism will be quantitatively evaluated by measuring the mean standardized uptake value (SUVmean) of bilateral hippocampi using ¹⁸F-FDG PET/CT. POD will be assessed twice daily from postoperative days 1 to 7 using the 3-Minute Diagnostic Interview for CAM (3D-CAM). The correlation between preoperative hippocampal SUVmean and POD incidence will be analyzed using univariate and multivariate logistic regression models. The predictive performance will be evaluated by constructing receiver operating characteristic (ROC) curves. Furthermore, the relationship between a peripheral insulin resistance marker (the triglyceride-glucose index, TyG index) and hippocampal metabolism levels will be analyzed.

Significance: This study aims to determine whether impaired preoperative hippocampal metabolism serves as an independent risk factor for POD. The findings are expected to provide a prospective functional neuroimaging biomarker for the early warning of POD and offer a theoretical basis for developing precise prevention strategies targeting cerebral metabolic abnormalities. This will facilitate the application of neuroimaging techniques in the field of perioperative brain dysfunction monitoring.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with type 2 diabetes mellitus (T2DM).
  • Age ≥ 65 years.
  • Scheduled for elective liver tumor resection surgery with an expected operative duration > 2 hours.
  • Underwent whole-body ¹⁸F-FDG PET/CT scan within 1 month prior to surgery.

Exclusion criteria

  • Patient declines to participate.
  • Inability to cooperate with cognitive assessments or a preoperative Mini-Mental State Examination (MMSE) score < 23.
  • American Society of Anesthesiologists (ASA) physical status classification ≥ IV.
  • History of organic brain disorders, including stroke, traumatic brain injury, or intracranial tumors.
  • History of psychiatric disorders or current use of antipsychotic medications.

Treatment and study plan

Primary outcomes

  1. Incidence of Postoperative Delirium (POD)

    Time frame: From surgery completion to postoperative day 7

    Assessed by the 3-Minute Diagnostic Interview for CAM (3D-CAM), administered twice daily.

Secondary outcomes

  1. Triglyceride-glucose (TyG) index

    Time frame: Within 7 days before surgery (preoperative baseline)

    Calculated as Ln [fasting triglycerides (mg/dL) × fasting glucose (mg/dL) / 2].

Other outcomes

  1. Incidence of Postoperative Adverse Events within 30 Days

    Time frame: From surgery completion to postoperative day 30

    Incidence of postoperative adverse events within 30 days, including but not limited to cardiovascular adverse events, ischemic stroke, pulmonary infection, acute kidney injury, and pain assessment.

Study contacts

Contact information is provided by the study sponsor or research team.

Danyang Geng, Master

CONTACT

[email protected]

86+17367522284

Weidong Mi, Professor

CONTACT

[email protected]

86+13381082966

Sponsors and collaborators

Lead sponsor

Chinese PLA General Hospital

Other

Registry information

Official study title

Preoperative Hippocampal Glucose Metabolism Levels and the Risk of Postoperative Delirium in Older Patients With Type 2 Diabetes: A Prospective Cohort Study

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Jan 27, 2026
Registry last updated
Jan 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.